First Citizens Bank & Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.93M | Sell |
79,991
-5,955
| -7% | -$156K | 0.03% | 224 |
|
|
2026
Q1 | $2.41M | Sell |
85,946
-2,431
| -3% | -$64.7K | 0.05% | 185 |
|
|
2025
Q4 | $2.2M | Sell |
88,377
-7,827
| -8% | -$197K | 0.05% | 191 |
|
|
2025
Q3 | $2.45M | Sell |
96,204
-6,441
| -6% | -$159K | 0.05% | 167 |
|
|
2025
Q2 | $2.49M | Sell |
102,645
-10,247
| -9% | -$239K | 0.05% | 164 |
|
|
2025
Q1 | $2.86M | Sell |
112,892
-144,305
| -56% | -$3.78M | 0.07% | 158 |
|
|
2024
Q4 | $6.82M | Sell |
257,197
-12,264
| -5% | -$333K | 0.13% | 85 |
|
|
2024
Q3 | $7.8M | Sell |
269,461
-819
| -0.3% | -$23.9K | 0.17% | 88 |
|
|
2024
Q2 | $7.56M | Buy |
270,280
+12,790
| +5% | +$352K | 0.14% | 81 |
|
|
2024
Q1 | $7.15M | Buy |
257,490
+110,915
| +76% | +$3.08M | 0.14% | 85 |
|
|
2023
Q4 | $4.22M | Sell |
146,575
-39,787
| -21% | -$1.2M | 0.08% | 102 |
|
|
2023
Q3 | $6.18M | Sell |
186,362
-4,870
| -3% | -$172K | 0.12% | 74 |
|
|
2023
Q2 | $7.01M | Buy |
191,232
+33,754
| +21% | +$1.31M | 0.13% | 73 |
|
|
2023
Q1 | $6.43M | Sell |
157,478
-709
| -0.4% | -$30.6K | 0.13% | 65 |
|
|
2022
Q4 | $8.11M | Sell |
158,187
-29,184
| -16% | -$1.4M | 0.25% | 38 |
|
|
2022
Q3 | $8.2M | Sell |
187,371
-3,375
| -2% | -$164K | 0.27% | 34 |
|
|
2022
Q2 | $10M | Buy |
190,746
+2,321
| +1% | +$118K | 0.35% | 29 |
|
|
2022
Q1 | $9.76M | Buy |
188,425
+1,495
| +0.8% | +$77.6K | 0.38% | 35 |
|
|
2021
Q4 | $11M | Sell |
186,930
-1,701
| -0.9% | -$84.3K | 0.43% | 32 |
|
|
2021
Q3 | $8.11M | Sell |
188,631
-5,038
| -3% | -$223K | 0.39% | 35 |
|
|
2021
Q2 | $7.58M | Sell |
193,669
-7,698
| -4% | -$299K | 0.36% | 36 |
|
|
2021
Q1 | $7.29M | Sell |
201,367
-2,654
| -1% | -$94.2K | 0.34% | 38 |
|
|
2020
Q4 | $7.51M | Sell |
204,021
-27,004
| -12% | -$991K | 0.38% | 36 |
|
|
2020
Q3 | $8.04M | Sell |
231,025
-7,628
| -3% | -$267K | 0.57% | 32 |
|
|
2020
Q2 | $7.4M | Buy |
238,653
+20,774
| +10% | +$706K | 0.62% | 36 |
|
|
2020
Q1 | $6.75M | Buy |
217,879
+48,103
| +28% | +$1.64M | 0.82% | 31 |
|
|
2019
Q4 | $6.31M | Buy |
169,776
+24,082
| +17% | +$858K | 0.61% | 41 |
|
|
2019
Q3 | $4.97M | Sell |
145,694
-6,367
| -4% | -$232K | 0.6% | 44 |
|
|
2019
Q2 | $6.25M | Buy |
152,061
+796
| +0.5% | +$31.6K | 0.68% | 30 |
|
|
2019
Q1 | $6.09M | Sell |
151,265
-22,689
| -13% | -$909K | 0.68% | 32 |
|
|
2018
Q4 | $7.2M | Buy |
173,954
+14,674
| +9% | +$609K | 0.88% | 23 |
|
|
2018
Q3 | $6.66M | Sell |
159,280
-881
| -0.6% | -$33.9K | 0.74% | 31 |
|
|
2018
Q2 | $5.51M | Buy |
160,161
+7,654
| +5% | +$262K | 0.68% | 36 |
|
|
2018
Q1 | $5.13M | Buy |
152,507
+36,012
| +31% | +$1.24M | 0.7% | 33 |
|
|
2017
Q4 | $4M | Sell |
116,495
-15,968
| -12% | -$544K | 0.54% | 55 |
|
|
2017
Q3 | $4.49M | Sell |
132,463
-47,424
| -26% | -$1.52M | 0.58% | 46 |
|
|
2017
Q2 | $5.73M | Sell |
179,887
-32,534
| -15% | -$1.03M | 0.74% | 30 |
|
|
2017
Q1 | $6.89M | Sell |
212,421
-174,066
| -45% | -$5.49M | 0.84% | 23 |
|
|
2016
Q4 | $11.9M | Sell |
386,487
-137,420
| -26% | -$4.2M | 1.31% | 12 |
|
|
2016
Q3 | $16.8M | Sell |
523,907
-12,711
| -2% | -$425K | 1.53% | 10 |
|
|
2016
Q2 | $17.9M | Sell |
536,618
-50,589
| -9% | -$1.61M | 1.61% | 9 |
|
|
2016
Q1 | $16.5M | Sell |
587,207
-315,442
| -35% | -$9.01M | 1.38% | 12 |
|
|
2015
Q4 | $27.6M | Buy |
902,649
+28,001
| +3% | +$881K | 2.02% | 5 |
|
|
2015
Q3 | $26.1M | Buy |
874,648
+232,315
| +36% | +$7.45M | 1.94% | 4 |
|
|
2015
Q2 | $20.4M | Buy |
642,333
+21,368
| +3% | +$696K | 1.41% | 8 |
|
|
2015
Q1 | $20.5M | Sell |
620,965
-12,065
| -2% | -$384K | 1.42% | 12 |
|
|
2014
Q4 | $18.7M | Sell |
633,030
-650
| -0.1% | -$18.6K | 1.43% | 13 |
|
|
2014
Q3 | $17.8M | Buy |
633,680
+168,859
| +36% | +$4.74M | 1.46% | 14 |
|
|
2014
Q2 | $13.1M | Buy |
464,821
+19,523
| +4% | +$557K | 1.12% | 25 |
|
|
2014
Q1 | $13.6M | Buy |
445,298
+2,314
| +0.5% | +$69K | 1.23% | 19 |
|
|
2013
Q4 | $12.9M | Sell |
442,984
-645,422
| -59% | -$18.8M | 1.17% | 24 |
|
|
2013
Q3 | $29.7M | Buy |
1,088,406
+6,943
| +0.6% | +$189K | 1.13% | 11 |
|
|
2013
Q2 | $28.7M | Buy |
+1,081,463
| New | +$29.9M | 1.18% | 11 |
|
Other funds holding PFE
First Citizens Bank & Trust's PFE Position: Q2 2026 in Review
First Citizens Bank & Trust reduced its Pfizer (PFE) stake by 6.9% in Q2 2026, selling an estimated $156K and leaving 79,991 shares worth $1.93M. The position accounts for 0.03% of the portfolio, ranked #224.
First Citizens Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.7M in Q3 2013. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- First Citizens Bank & Trust held 79,991 shares of Pfizer worth $1.93M as of Q2 2026.
- First Citizens Bank & Trust sold 5,955 Pfizer shares in Q2 2026, an estimated $156K.
- Pfizer made up 0.03% of First Citizens Bank & Trust's portfolio in Q2 2026, its #224 holding.
- First Citizens Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- First Citizens Bank & Trust's Pfizer position peaked at $29.7M in Q3 2013.
- 2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.